Osimertinib Active Not Recruiting Phase 1 Trials for Advanced Non Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02143466AZD9291 in Combination With Ascending Doses of Novel Therapeutics